Global Interventional Oncology Market
2017-2021
No of Pages – 70
Publishing Date - March 13, 2017
Browse detailed TOC, Tables, Figures, Charts in Global Interventional Oncology Market
2017-2021 at - http://www.360marketupdates.com/10543531
About Interventional Oncology
Interventional oncology procedures involve the diagnosis and treatment of cancer and cancer-related
problems by using minimally invasive (MI) procedures performed under image guidance.
Interventional oncology uses X-ray, ultrasound, computed tomography (CT) or magnetic resonance
imaging (MRI) to guide accessories and instruments, such as ablation electrodes, biopsy needles,
guidewires, and intravascular catheters that allow the treatment of a tumor located in some part of the
body. Interventional oncology treatments are regularly carried out by interventional radiologists with
appropriate settings and facilities. Interventional oncology is used to treat primary or metastatic
cancer, which includes liver cancer, lung cancer, kidney cancer, bone cancer, breast cancer, and
prostate and pancreatic cancer.
Technavio’s analysts forecast the global interventional oncology market to grow at a CAGR of
11.17% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global interventional oncology
market for 2017-2021. To calculate the market size, the report considers the revenue generated from
the sales of interventional oncology.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Interventional Oncology Market 2017-2021, has been prepared based on
an in-depth market analysis with inputs from industry experts. The report covers the market
landscape and its growth prospects over the coming years. The report also includes a discussion of
the key vendors operating in this market.
Key vendors
• BTG
• Boston Scientific
• Medtronic
• Merit Medical
• TERUMO CORPORATION